Biocept Inc (NASDAQ:BIOC)
| 0.30 Delayed Data As of 3:54pm ET |  +0.008 / +2.74%Today’s Change | 0.24 Today|||52-Week Range 2.43 | -43.40% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | -16.9M | -18.4M | -21.6M | -24.6M | |
| Depreciation | 261.4K | 322.0K | 575.7K | 800.9K | ||
| Total Other Cash Flow | 1.5M | 1.6M | 1.2M | 614.3K | ||
| Funds From Operations | -15.2M | -16.4M | -19.8M | -23.2M | ||
| Funds From/For Other Operating Expenses | -70.2K | -748.6K | -144.6K | -801.1K | ||
| Net Cash Flow - Operating Activities | -15.2M | -15.7M | -19.7M | -22.4M | ||
| Investing | Capital Expenditures | -165.2K | -482.1K | -1.4M | -145.3K | |
| Fixed Asset Disposal | -- | 30.7K | 0.00 | -- | ||
| Net Cash Flow Investing | -165.2K | -451.4K | -1.4M | -145.3K | ||
| Financing | Short Term Borrowings | -71.2K | -510.1K | -465.3K | -559.1K | |
| Long Term Borrowings | 0.00 | 0.00 | 150.8K | 0.00 | ||
| Long Term Debt Reduction | -700.1K | -1.3M | -2.1M | -1.4M | ||
| Net Proceeds Stock Sale | 19.5M | 13.8M | 21.0M | 25.7M | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Cash Flow - Financing | 18.8M | 11.9M | 18.6M | 23.8M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | 3.5M | -4.2M | -2.5M | 1.3M | ||
